Actively Recruiting

Phase Not Applicable
Age: 5Years - 13Years
All Genders
NCT07244042

Effects of Modified CIMT With and Without PNF

Led by Riphah International University · Updated on 2025-11-24

20

Participants Needed

1

Research Sites

15 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This randomized clinical trial investigates the effects of modified CIMT with and without the addition of PNF techniques on upper extremity function in pediatric stroke patients, aiming to determine whether combining these approaches yields superior motor recovery.This study will be conducted as a randomized clinical trial over an intervention period of six-week. 20 pediatric stroke patients with upper extremity impairments will be randomly assigned to two groups: one receiving modified CIMT alone and the other receiving modified CIMT combined with PNF techniques. Pre- and post-intervention assessments will be conducted using standardized measures, such as Pediatric Motor Activity Log(PMAL) for upper extremity function, Modified Ashworth Scale(MAS) and Manual Ability Classification System(MACS). Muscle tone and physical activity status will also be evaluated. Data will be entered and analyzed in SPSS V-26.0 to compare improvements in motor function between the two groups, with statistical significance assessed to determine the efficacy of each intervention

CONDITIONS

Official Title

Effects of Modified CIMT With and Without PNF

Who Can Participate

Age: 5Years - 13Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Pediatric patients with confirmed diagnosis of stroke
  • Children between 5 to 13 years old
  • Modified Ashworth Scale spasticity level 1 or 2
  • Manual Ability Classification System score between 3 to 6
  • Gross Motor Function Classification System level 1 or 2
  • At least 20 degrees of active wrist extension from full flexion, 10 degrees of active thumb extension or abduction, and 10 degrees of active extension in finger joints on affected upper extremity
Not Eligible

You will not qualify if you...

  • Patients with epilepsy or seizure disorder
  • Patients with history of botulinum toxin injection
  • Patients with cognitive impairment
  • Patients with fracture or any surgical procedure in the upper extremity

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Imran Amjad

Lahore, Punjab Province, Pakistan, 5400

Actively Recruiting

Loading map...

Research Team

I

IMRAN AMJAD, PhD

CONTACT

M

Muhammad Asif Javed, MS-PT

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here